GTF2A1 | general transcription factor IIA, 1, 19/37kDa | 14q31 | 0.539 | 0.65 | 0
|
RIF1 | replication timing regulatory factor 1 | 2q23.3 | 0.534 | 0.689 | 0
|
RNF168 | ring finger protein 168, E3 ubiquitin protein ligase | 3q29 | 0.533 | 0.688 | 0
|
STRN | striatin, calmodulin binding protein | 2p22.2 | 0.519 | 0.666 | 0
|
C9orf129 | chromosome 9 open reading frame 129 | 9q22.31 | 0.518 | 0.659 | 0
|
HACD2 | 3-hydroxyacyl-CoA dehydratase 2 | 3q21.1 | 0.518 | 0.664 | 0
|
PRKAR2A | protein kinase, cAMP-dependent, regulatory, type II, alpha | 3p21.3-p21.2 | 0.516 | 0.633 | 0
|
DDI2 | DNA-damage inducible 1 homolog 2 | 1p36.13 | 0.511 | 0.693 | 0
|
UBXN7 | UBX domain protein 7 | 3q29 | 0.51 | 0.605 | 0
|
ASXL2 | additional sex combs like transcriptional regulator 2 | 2p24.1 | 0.509 | 0.673 | 0
|
ETV3 | ets variant 3 | 1q21-q23 | 0.506 | 0.629 | 0
|
CSNK2A3 | casein kinase 2, alpha 3 polypeptide | 11p15.3 | 0.506 | 0.69 | 0
|
UHMK1 | U2AF homology motif (UHM) kinase 1 | 1q23.1 | 0.493 | 0.645 | 0
|
CEP97 | centrosomal protein 97kDa | 3q12.3 | 0.493 | 0.6 | 0
|
TOR1AIP2 | torsin A interacting protein 2 | 1q25.2 | 0.492 | 0.619 | 0
|
CASC5 | cancer susceptibility candidate 5 | 15q14 | 0.492 | 0.644 | 0
|
BARD1 | BRCA1 associated RING domain 1 | 2q35 | 0.49 | 0.651 | 0
|
GTF3C4 | general transcription factor IIIC, polypeptide 4, 90kDa | 9q34.3 | 0.489 | 0.635 | 0
|
CCNT1 | cyclin T1 | 12q13.11 | 0.489 | 0.671 | 0
|
RNF169 | ring finger protein 169 | 11q13.4 | 0.489 | 0.569 | 0
|
PRR11 | proline rich 11 | 17q23.2 | 0.488 | 0.647 | 0
|
REST | RE1-silencing transcription factor | 4q12 | 0.485 | 0.631 | 0
|
RC3H2 | ring finger and CCCH-type domains 2 | 9q34 | 0.483 | 0.661 | 0
|
STAG1 | stromal antigen 1 | 3q22.2-q22.3 | 0.482 | 0.606 | 0
|
PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | 3q26.3 | 0.472 | 0.602 | 0
|
ADAM17 | ADAM metallopeptidase domain 17 | 2p25 | 0.47 | 0.607 | 0
|
NUP153 | nucleoporin 153kDa | 6p22.3 | 0.467 | 0.62 | 0
|
ANKRD36BP1 | ankyrin repeat domain 36B pseudogene 1 | 1q24.2 | 0.465 | 0.659 | 0
|
PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 8q11 | 0.462 | 0.605 | 0
|
RRAGC | Ras-related GTP binding C | 1p34 | 0.462 | 0.526 | 0
|
CLSPN | claspin | 1p34.3 | 0.455 | 0.606 | 0
|
SLC25A40 | solute carrier family 25, member 40 | 7q21.12 | 0.449 | 0.633 | 0
|
RBL1 | retinoblastoma-like 1 | 20q11.23 | 0.446 | 0.603 | 0
|
MPZL3 | myelin protein zero-like 3 | 11q23.3 | 0.441 | 0.611 | 0
|
TAF13 | TAF13 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 18kDa | 1p13.3 | 0.439 | 0.516 | 0
|
CDK12 | cyclin-dependent kinase 12 | 17q12 | 0.439 | 0.595 | 0
|
NUP155 | nucleoporin 155kDa | 5p13.1 | 0.437 | 0.611 | 0
|
GPATCH11 | G patch domain containing 11 | 2p22.2 | 0.435 | 0.604 | 0
|
HNRNPR | heterogeneous nuclear ribonucleoprotein R | 1p36.12 | 0.434 | 0.623 | 0
|
ZNF688 | zinc finger protein 688 | 16p11.2 | 0.43 | -0.567 | 0
|
WDR31 | WD repeat domain 31 | 9q33.1 | 0.429 | 0.508 | 0
|
SMC3 | structural maintenance of chromosomes 3 | 10q25 | 0.426 | 0.551 | 0
|
NDC1 | NDC1 transmembrane nucleoporin | 1p32.3 | 0.419 | 0.628 | 0
|
KPNA6 | karyopherin alpha 6 (importin alpha 7) | 1p35.1 | 0.417 | 0.638 | 0
|
TUBGCP4 | tubulin, gamma complex associated protein 4 | 15q15.3 | 0.415 | 0.582 | 0
|
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Xp11.22 | 0.415 | 0.524 | 0
|
DENND2C | DENN/MADD domain containing 2C | 1p13.2-p13.1 | 0.413 | 0.529 | 0
|
NPFF | neuropeptide FF-amide peptide precursor | 12q13.13 | 0.403 | -0.532 | 0
|
INCENP | inner centromere protein antigens 135/155kDa | 11q12.3 | 0.402 | 0.557 | 0
|
FAM114A1 | family with sequence similarity 114, member A1 | 4p14 | 0.4 | 0.48 | 0
|
MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 1p36 | 0.396 | 0.545 | 0
|
YIPF6 | Yip1 domain family, member 6 | Xq13.1 | 0.395 | 0.533 | 0
|
ACBD3 | acyl-CoA binding domain containing 3 | 1q41 | 0.394 | 0.565 | 0
|
NDUFB8 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa | 10q24.31 | 0.392 | -0.491 | 0
|
MFN1 | mitofusin 1 | 3q26.32 | 0.391 | 0.473 | 0
|
SLC25A24 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 | 1p13.2 | 0.39 | 0.555 | 0
|
ABHD14A | abhydrolase domain containing 14A | 3p21.1 | 0.387 | -0.441 | 0
|
THRAP3 | thyroid hormone receptor associated protein 3 | 1p34.3 | 0.386 | 0.577 | 0
|
RCAN3 | RCAN family member 3 | 1p36.11 | 0.384 | 0.578 | 0
|
DR1 | down-regulator of transcription 1 | 1p22.1 | 0.384 | 0.526 | 0
|
SERINC3 | serine incorporator 3 | 20q13.12 | 0.376 | 0.493 | 0
|
GNPTG | N-acetylglucosamine-1-phosphate transferase, gamma subunit | 16p13.3 | 0.375 | -0.514 | 0
|
RPL28 | ribosomal protein L28 | 19q13.4 | 0.375 | -0.434 | 0
|
AVL9 | AVL9 homolog (S. cerevisiase) | 7p14.3 | 0.37 | 0.58 | 0
|
SAP130 | Sin3A-associated protein, 130kDa | 2q14.3 | 0.37 | 0.538 | 0
|
GSTCD | glutathione S-transferase, C-terminal domain containing | 4q24 | 0.369 | 0.519 | 0
|
MCM4 | minichromosome maintenance complex component 4 | 8q12-q13 | 0.368 | 0.554 | 0
|
CXorf56 | chromosome X open reading frame 56 | Xq24 | 0.368 | 0.487 | 0
|
NRAS | neuroblastoma RAS viral (v-ras) oncogene homolog | 1p13.2 | 0.367 | 0.492 | 0
|
CST3 | cystatin C | 20p11.2 | 0.366 | -0.51 | 0
|
AGO3 | argonaute RISC catalytic component 3 | 1p34 | 0.363 | 0.474 | 0
|
CD63 | CD63 molecule | 12q12-q13 | 0.362 | -0.481 | 0
|
RAD21 | RAD21 cohesin complex component | 8q24.11 | 0.362 | 0.537 | 0
|
MCTS2P | malignant T cell amplified sequence 2, pseudogene | 20q11.21 | 0.362 | 0.493 | 0
|
DYNLL2 | dynein, light chain, LC8-type 2 | 17q22 | 0.36 | 0.346 | 2.38e-13
|
ATF6 | activating transcription factor 6 | 1q23.3 | 0.358 | 0.47 | 0
|
SEC23B | Sec23 homolog B, COPII coat complex component | 20p11.23 | 0.357 | 0.481 | 0
|
CEP85 | centrosomal protein 85kDa | 1p36.11 | 0.357 | 0.56 | 0
|
EAF1 | ELL associated factor 1 | 3p25.1 | 0.357 | 0.461 | 0
|
HIGD2A | HIG1 hypoxia inducible domain family, member 2A | 5q35.2 | 0.355 | -0.477 | 0
|
FAM167B | family with sequence similarity 167, member B | 1p35.1 | 0.351 | -0.483 | 0
|
RAD18 | RAD18 E3 ubiquitin protein ligase | 3p25.3 | 0.349 | 0.441 | 0
|
PTBP3 | polypyrimidine tract binding protein 3 | 9q32 | 0.345 | 0.45 | 0
|
RBMXL1 | RNA binding motif protein, X-linked-like 1 | 1p22.2 | 0.343 | 0.42 | 0
|
B4GALT7 | xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 | 5q35.1-q35.3 | 0.342 | -0.45 | 0
|
SNIP1 | Smad nuclear interacting protein 1 | 1p34.3 | 0.337 | 0.48 | 0
|
TMEM39A | transmembrane protein 39A | 3q13.33 | 0.335 | 0.425 | 0
|
PRDX5 | peroxiredoxin 5 | 11q13 | 0.329 | -0.386 | 1.01e-17
|
HSPA13 | heat shock protein 70kDa family, member 13 | 21q11.1 | 0.329 | 0.444 | 0
|
TXNRD2 | thioredoxin reductase 2 | 22q11.21 | 0.324 | -0.303 | 2.05e-10
|
GMEB1 | glucocorticoid modulatory element binding protein 1 | 1p35 | 0.323 | 0.546 | 0
|
REEP3 | receptor accessory protein 3 | 10q21.3 | 0.323 | 0.405 | 0
|
COPB2 | coatomer protein complex, subunit beta 2 (beta prime) | 3q23 | 0.322 | 0.429 | 0
|
NOL9 | nucleolar protein 9 | 1p36.31 | 0.322 | 0.519 | 0
|
ARMC8 | armadillo repeat containing 8 | 3q22 | 0.319 | 0.327 | 5.91e-12
|
UBE4B | ubiquitination factor E4B | 1p36.1 | 0.318 | 0.464 | 0
|
ERMARD | ER membrane-associated RNA degradation | 6q27 | 0.315 | -0.397 | 0
|
COX7C | cytochrome c oxidase subunit VIIc | 5q14 | 0.315 | -0.371 | 2.38e-15
|
TMED5 | transmembrane p24 trafficking protein 5 | 1p22.1 | 0.313 | 0.411 | 0
|
SEC24D | SEC24 homolog D, COPII coat complex component | 4q26 | 0.313 | 0.352 | 9.37e-14
|
CTDSP1 | CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 1 | 2q35 | 0.311 | -0.37 | 3.06e-15
|
CIT | citron rho-interacting serine/threonine kinase | 12q24.23 | 0.309 | 0.387 | 0
|
CSDE1 | cold shock domain containing E1, RNA-binding | 1p13.2 | 0.307 | 0.45 | 0
|
AMY2B | amylase, alpha 2B (pancreatic) | 1p21 | 0.302 | -0.382 | 1.28e-16
|
OTUD6B | OTU domain containing 6B | 8q21.3 | 0.296 | 0.382 | 1.12e-16
|
SNRNP40 | small nuclear ribonucleoprotein 40kDa (U5) | 1p35.2 | 0.295 | 0.406 | 0
|
CD81 | CD81 molecule | 11p15.5 | 0.295 | -0.394 | 0
|
FES | FES proto-oncogene, tyrosine kinase | 15q26.1 | 0.294 | -0.363 | 1.2e-14
|
GART | phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | 21q22.11 | 0.289 | 0.502 | 0
|
MXD4 | MAX dimerization protein 4 | 4p16.3 | 0.288 | -0.425 | 0
|
ABCD4 | ATP-binding cassette, sub-family D (ALD), member 4 | 14q24 | 0.287 | -0.359 | 2.51e-14
|
PPP1R8 | protein phosphatase 1, regulatory subunit 8 | 1p35.3 | 0.286 | 0.462 | 0
|
EMC1 | ER membrane protein complex subunit 1 | 1p36.13 | 0.284 | 0.503 | 0
|
TCEB3 | transcription elongation factor B (SIII), polypeptide 3 (110kDa, elongin A) | 1p36.1 | 0.278 | 0.421 | 0
|
GHDC | GH3 domain containing | 17q21.2 | 0.273 | -0.306 | 1.27e-10
|
KLHL7 | kelch-like family member 7 | 7p15.3 | 0.273 | 0.377 | 6.31e-16
|
ITIH4 | inter-alpha-trypsin inhibitor heavy chain family, member 4 | 3p21.1 | 0.262 | -0.415 | 0
|
TMBIM4 | transmembrane BAX inhibitor motif containing 4 | 12q14.3 | 0.259 | -0.324 | 8.93e-12
|
C6orf163 | chromosome 6 open reading frame 163 | 6q15 | 0.258 | -0.259 | 6.59e-08
|
APOL2 | apolipoprotein L, 2 | 22q12.3 | 0.242 | -0.337 | 1.18e-12
|
PHF11 | PHD finger protein 11 | 13q14.11 | 0.236 | -0.377 | 5.89e-16
|
GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 | 1p36.33 | 0.233 | 0.349 | 1.45e-13
|
PRKAR2B | protein kinase, cAMP-dependent, regulatory, type II, beta | 7q22.3 | 0.225 | -0.037 | 0.447
|
GUCA1B | guanylate cyclase activator 1B (retina) | 6p21.1 | 0.224 | -0.282 | 3.65e-09
|